Abstract
Docking ligands into an ensemble of NMR conformers is essential to structure-based drug discovery if only NMR structures are available for the target. However, sequentially docking ligands into each NMR conformer through standard single-receptor-structure docking, referred to as sequential docking, is computationally expensive for large-scale database screening because of the large number of NMR conformers involved. Recently, we developed an efficient ensemble docking algorithm to consider protein structural variations in ligand binding. The algorithm simultaneously docks ligands into an ensemble of protein structures and achieves comparable performance to sequential docking without significant increase in computational time over single-structure docking. Here, we applied this algorithm to docking with NMR structures. The HIV-1 protease was used for validation in terms of docking accuracy and virtual screening. Ensemble docking of the NMR structures identified 91% of the known inhibitors under the criterion of RMSD < 2.0 A for the best-scored conformation, higher than the average success rate of single docking of individual crystal structures (66%). In the virtual screening test, on average, ensemble docking of the NMR structures obtained higher enrichments than single-structure docking of the crystal structures. In contrast, docking of either the NMR minimized average structure or a single NMR conformer performed less satisfactorily on both binding mode prediction and virtual screening, indicating that a single NMR structure may not be suitable for docking calculations. The success of ensemble docking of the NMR structures suggests an efficient alternative method for standard single docking of crystal structures and for considering protein flexibility.
MeSH Terms
Algorithms
Drug Design
Drug Evaluation, Preclinical
HIV Protease/chemistry,metabolism
HIV Protease Inhibitors/chemistry,pharmacology
HIV-1/drug effects,enzymology
Humans
In Vitro Techniques
Ligands
Models, Molecular
Nuclear Magnetic Resonance, Biomolecular
Protein Binding
User-Computer Interface
Chemicals
HIV Protease Inhibitors
Ligands
HIV Protease
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Huang Sheng-You
Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA.
Zou Xiaoqin
References (26)
26 references, click to expand
-
Soft docking and multiple receptor conformations in virtual screening.
J Med Chem. 2004 Oct 7;47(21):5076-84
PMID: 15456251
-
The Protein Data Bank.
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
PMID: 10592235
-
Molecular recognition and docking algorithms.
Annu Rev Biophys Biomol Struct. 2003;32:335-73
PMID: 12574069
-
Comparing protein-ligand docking programs is difficult.
Proteins. 2005 Aug 15;60(3):325-32
PMID: 15937897
-
Modeling correlated main-chain motions in proteins for flexible molecular recognition.
Proteins. 2004 Nov 1;57(2):243-61
PMID: 15340912
-
Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking.
Proteins. 2007 Feb 1;66(2):399-421
PMID: 17096427
-
Testing a flexible-receptor docking algorithm in a model binding site.
J Mol Biol. 2004 Apr 9;337(5):1161-82
PMID: 15046985
-
A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening.
J Mol Graph Model. 2000 Jun;18(3):247-57, 302-4
PMID: 11021541
-
An iterative knowledge-based scoring function to predict protein-ligand interactions: I. Derivation of interaction potentials.
J Comput Chem. 2006 Nov 30;27(15):1866-75
PMID: 16983673
-
An iterative knowledge-based scoring function to predict protein-ligand interactions: II. Validation of the scoring function.
J Comput Chem. 2006 Nov 30;27(15):1876-82
PMID: 16983671
-
Molecular Recognition of Proteinminus signLigand Complexes: Applications to Drug Design.
Chem Rev. 1997 Aug 5;97(5):1359-1472
PMID: 11851455
-
Developing a dynamic pharmacophore model for HIV-1 integrase.
J Med Chem. 2000 Jun 1;43(11):2100-14
PMID: 10841789
-
Representing receptor flexibility in ligand docking through relevant normal modes.
J Am Chem Soc. 2005 Jul 6;127(26):9632-40
PMID: 15984891
-
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.
J Med Chem. 2005 Apr 7;48(7):2432-44
PMID: 15801834
-
Lead discovery using molecular docking.
Curr Opin Chem Biol. 2002 Aug;6(4):439-46
PMID: 12133718
-
Comparison of X-ray and NMR structures: is there a systematic difference in residue contacts between X-ray- and NMR-resolved protein structures?
Proteins. 2005 Jul 1;60(1):139-47
PMID: 15856480
-
FlexE: efficient molecular docking considering protein structure variations.
J Mol Biol. 2001 Apr 27;308(2):377-95
PMID: 11327774
-
Incorporating protein flexibility in structure-based drug discovery: using HIV-1 protease as a test case.
J Am Chem Soc. 2004 Oct 20;126(41):13276-81
PMID: 15479081
-
Principles of docking: An overview of search algorithms and a guide to scoring functions.
Proteins. 2002 Jun 1;47(4):409-43
PMID: 12001221
-
Design, docking, and evaluation of multiple libraries against multiple targets.
Proteins. 2001 Feb 15;42(3):296-318
PMID: 11151003
-
Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy.
J Med Chem. 2004 Jan 1;47(1):45-55
PMID: 14695819
-
Conformational flexibility models for the receptor in structure based drug design.
Curr Pharm Des. 2003;9(20):1635-48
PMID: 12871062
-
Molecular docking to ensembles of protein structures.
J Mol Biol. 1997 Feb 21;266(2):424-40
PMID: 9047373
-
Protein flexibility is an important component of structure-based drug discovery.
Curr Pharm Des. 2002;8(17):1571-8
PMID: 12052201
-
Protein flexibility in ligand docking and virtual screening to protein kinases.
J Mol Biol. 2004 Mar 12;337(1):209-25
PMID: 15001363
-
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases.
J Comput Aided Mol Des. 2001 May;15(5):411-28
PMID: 11394736